Physician

Joseph Vincent Lillis, M.D.

According to 2025 Medicare claims, Joseph Lillis, M.D. (NPI: 1225213432) practices dermatology in the Fort Collins-Loveland, CO market, with the plurality of this provider's patient population coming from Larimer, CO. This provider's primary affiliated billing organization is COLORADO DERMATOLOGY GROUP, PLLC (NPI: 1144776238; TIN: 813218047) and primary practice location at 80525-3430.

Lillis' data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 788 traditional Medicare patients, billed 8,744 HCPCS/CPT codes, and received $540,323 in Medicare payments. The top billing code was 11102 (Biopsy of related skin growth, first growth). Part D data shows 884 prescription claims across 459 beneficiaries totaling $65,266 in drug costs, led by Clobetasol Propionate (Clobetasol Propionate). Open Payments data shows 10 records totaling $209. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing did not follow a clear longitudinal pattern. Concurrently, Part D prescription costs started with an early spike, then settled into a lower baseline, moving from $126,908 to $65,266. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$477K$954K2015 Medicare payment: $953,797 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $815,202 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $563,225 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $661,855 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $705,420 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $658,486 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $696,779 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $674,133 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $679,761 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $540,323 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
20151,90116,615$953,797
20161,18412,401$815,202
20175027,381$563,225
201867213,811$661,855
20197249,622$705,420
20207459,565$658,486
202178910,527$696,779
202282811,232$674,133
202380611,135$679,761
20247888,744$540,323

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$65K$129K2015 Drug cost: $126,908 (USD; Tot_Drug_Cst)2016 Drug cost: $129,008 (USD; Tot_Drug_Cst)2017 Drug cost: $15,646 (USD; Tot_Drug_Cst)2018 Drug cost: $30,402 (USD; Tot_Drug_Cst)2019 Drug cost: $70,494 (USD; Tot_Drug_Cst)2020 Drug cost: $17,643 (USD; Tot_Drug_Cst)2021 Drug cost: $23,849 (USD; Tot_Drug_Cst)2022 Drug cost: $18,303 (USD; Tot_Drug_Cst)2023 Drug cost: $36,702 (USD; Tot_Drug_Cst)2024 Drug cost: $65,266 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
2015345693$126,908
2016407802$129,008
2017232465$15,646
2018253516$30,402
2019331632$70,494
2020383779$17,643
2021451937$23,849
2022365696$18,303
2023447804$36,702
2024459884$65,266

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
11102Biopsy of related skin growth, first growth354469$65
99213Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more582970$58
17000Destruction of precancer skin growth, 1 growth471666$34
88305Pathology examination of tissue using a microscope, intermediate complexity321701$26
17003Destruction of precancer skin growth, 2-14 growths4243,747$5

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
Clobetasol PropionateClobetasol Propionate792,316$3,074
CephalexinCephalexin2741,423$1,474
Mometasone FuroateMometasone Furoate721,904$1,308
TacrolimusTacrolimus12355$1,295
Triamcinolone AcetonideTriamcinolone Acetonide982,851$970

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.10$209ABBVIE INC.
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Joseph Vincent Lillis, M.D.?

Tedicare shows public-source Medicare data for Joseph Vincent Lillis, M.D. (NPI 1225213432), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Joseph Vincent Lillis, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Joseph Vincent Lillis, M.D.?

Joseph Vincent Lillis, M.D. is linked to COLORADO DERMATOLOGY GROUP, PLLC (billing NPI 1144776238) in the available physician profile data.

Does Joseph Vincent Lillis, M.D. have Open Payments data?

Joseph Vincent Lillis, M.D. has 10 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.